(S)-9-氟-3-甲基-10-(4-甲基哌嗪-1-基)-7-氧代-2,3-二氢-7H-[1,4]恶嗪并[2,3,4-ij]喹啉-6-羧酸盐酸盐

英文名： (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride

别名：盐酸左氧氟沙星;(3S)-(-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-7H-吡啶并[1,2,3-de]-[1,4]苯并噁嗪-6-羧酸盐酸盐;左氧氟沙星盐酸盐;(3S)-(-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-7H-吡啶并[1,2,3-de]-[1,4]苯并嗪-6-羧酸盐酸盐;3-碘邻苯二甲酸酐;盐酸左旋氧氟沙星;高铁酸钾;左氟沙星·盐酸盐;左氟沙星盐酸盐;左氧氟沙星;盐酸左氧氟沙星(标准品) 盐酸左氧氟沙星;(3S)-(-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-7H-吡啶并[1,2,3-de]-[1,4]苯并噁嗪-6-羧酸盐酸盐;左氧氟沙星盐酸盐;(3S)-(-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-7H-吡啶并[1,2,3-de]-[1,4]苯并嗪-6-羧酸盐酸盐;3-碘邻苯二甲酸酐;盐酸左旋氧氟沙星;高铁酸钾;左氟沙星·盐酸盐;左氟沙星盐酸盐;左氧氟沙星;盐酸左氧氟沙星(标准品) 展开

CAS No. : 177325-13-2

分子式 : C₁₈H₂₁ClFN₃O₄

分子量 : 397.82

大包装询价? 收藏产品

中文名称	(S)-9-氟-3-甲基-10-(4-甲基哌嗪-1-基)-7-氧代-2,3-二氢-7H-[1,4]恶嗪并[2,3,4-ij]喹啉-6-羧酸盐酸盐
中文别名	盐酸左氧氟沙星;(3S)-(-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-7H-吡啶并[1,2,3-de]-[1,4]苯并噁嗪-6-羧酸盐酸盐;左氧氟沙星盐酸盐;(3S)-(-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-7H-吡啶并[1,2,3-de]-[1,4]苯并嗪-6-羧酸盐酸盐;3-碘邻苯二甲酸酐;盐酸左旋氧氟沙星;高铁酸钾;左氟沙星·盐酸盐;左氟沙星盐酸盐;左氧氟沙星;盐酸左氧氟沙星(标准品)
英文名称	(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride
英文别名	Levofloxacin Hydrochloride;(3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid monohydrochloride;7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 9-fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo-,hydrochloride (1:1), (3S)-;3S)-9-Fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid Monohydrochlori;LEVOFLOXACIN HCL;(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride;(3S)-9-FLUORO-2,3-DIHYDRO-3-METHYL-10-(4-METHYL-1-PIPERAZINYL)-7-OXO-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC A...;AC-7617;S454;-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl);-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride;HTN0D03VRZ;Weilisu;Levofloxacin Hydrochloride,(S);BCP24629;API0003162;(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;hydrochloride;Levofloxacin (hydrochloride);CHEMBL2237108;D78064;EN300-19833640;S-(-)-Ofloxacin hydrochloride;MFCD03265511;AKOS007930523;AKOS015896241;C18H21ClFN3O4;HY-B0330B;LEVOFLOXACIN HYDROCHLORIDE [WHO-DD];AS-16117;Levofloxacin Hydrochloride Impurity A;(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride;J-011269;(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0,5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid hydrochloride;(3S)-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid,9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-,HCl;7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, monohydrochloride, (S)-;7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrochloride (1:1), (3S)-;DTXSID80432709;UNII-HTN0D03VRZ;177325-13-2;CS-0014296;SCHEMBL554426;2254176-11-7;Q27280093;Levofloxacinhydrochloride;AMY22188;Levofloxacin hydrochloride;(-)-Ofloxacin hydrochloride;DA-74975;DTXCID50383537;Weilisu; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Monohydrochloride; (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Monohydrochloride;
CAS No.	177325-13-2
分子式	C₁₈H₂₁ClFN₃O₄
分子量	397.82

象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group

搜索质检报告(COA)

搜索MSDS

相关产品